Rare epithelial breast cancer: surgery and adjuvant therapy

Breast cancer is a heterogenous disease, exhibiting a wide range of morphological phenotypes shaping its prognosis and clinical course. However, optimal management of rarer breast cancer subtypes is often undefined and controversial in literature due to the lack of large studies and randomised trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelwahed, Aida, Ahmed, Muneer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797705/
https://www.ncbi.nlm.nih.gov/pubmed/35117126
http://dx.doi.org/10.21037/tcr.2019.05.12
_version_ 1784641616319873024
author Abdelwahed, Aida
Ahmed, Muneer
author_facet Abdelwahed, Aida
Ahmed, Muneer
author_sort Abdelwahed, Aida
collection PubMed
description Breast cancer is a heterogenous disease, exhibiting a wide range of morphological phenotypes shaping its prognosis and clinical course. However, optimal management of rarer breast cancer subtypes is often undefined and controversial in literature due to the lack of large studies and randomised trials. This review aims to discuss the treatment of 13 rare epithelial subtypes, focussing on surgery and adjuvant therapies.
format Online
Article
Text
id pubmed-8797705
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87977052022-02-02 Rare epithelial breast cancer: surgery and adjuvant therapy Abdelwahed, Aida Ahmed, Muneer Transl Cancer Res Review Article Breast cancer is a heterogenous disease, exhibiting a wide range of morphological phenotypes shaping its prognosis and clinical course. However, optimal management of rarer breast cancer subtypes is often undefined and controversial in literature due to the lack of large studies and randomised trials. This review aims to discuss the treatment of 13 rare epithelial subtypes, focussing on surgery and adjuvant therapies. AME Publishing Company 2019-10 /pmc/articles/PMC8797705/ /pubmed/35117126 http://dx.doi.org/10.21037/tcr.2019.05.12 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Review Article
Abdelwahed, Aida
Ahmed, Muneer
Rare epithelial breast cancer: surgery and adjuvant therapy
title Rare epithelial breast cancer: surgery and adjuvant therapy
title_full Rare epithelial breast cancer: surgery and adjuvant therapy
title_fullStr Rare epithelial breast cancer: surgery and adjuvant therapy
title_full_unstemmed Rare epithelial breast cancer: surgery and adjuvant therapy
title_short Rare epithelial breast cancer: surgery and adjuvant therapy
title_sort rare epithelial breast cancer: surgery and adjuvant therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797705/
https://www.ncbi.nlm.nih.gov/pubmed/35117126
http://dx.doi.org/10.21037/tcr.2019.05.12
work_keys_str_mv AT abdelwahedaida rareepithelialbreastcancersurgeryandadjuvanttherapy
AT ahmedmuneer rareepithelialbreastcancersurgeryandadjuvanttherapy

Ejemplares similares